BRCA2 Mutation Carrier

specific

A carrier of a mutation in BRCA2 gene.

Centers

Active Trials

$12M

Cancer Funding

Top Centers for BRCA2 Mutation Carrier(40)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive High-Volume Research Center	High-Volume Research Center	1	$6M	85.2
2	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive High-Volume Research Center	High-Volume Research Center	1	$280K	82.6
3	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	66.4
4	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	66.4
5	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	66.4
6	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive Active Research Program	Active Research Program	1	—	66.4
7	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	66.4
8	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	66.4
9	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	66.4
10	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	66.4
11	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	—	$4M	61.8
12	Cedars-Sinai CancerLos Angeles, CA Active Research Program	Active Research Program	—	$1M	60.9
13	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive		—	—	43.9
14	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		—	—	43.9
15	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive		—	—	43.9
16	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive		—	—	43.9
17	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive		—	—	43.9
18	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive		—	—	43.9
19	UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive		—	—	43.9
20	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive		—	—	43.9
21	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive		—	—	43.9
22	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	—	43.9
23	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	—	43.9
24	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	—	43.9
25	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive		—	—	43.9
26	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	—	43.9
27	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive		—	—	43.9
28	Cleveland Clinic Cancer CenterCleveland, OH		—	—	43.9
29	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	—	43.9
30	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive		—	—	43.9
31	University of Illinois Cancer CenterChicago, IL		—	—	43.9
32	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	—	43.9
33	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	—	43.9
34	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive		—	—	43.9
35	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX		—	—	43.9
36	Cancer Center at IllinoisUrbana, IL		—	—	43.9
37	Penn State Cancer InstituteHershey, PA		—	—	43.9
38	The University of Vermont Cancer CenterBurlington, VT		—	—	43.9
39	Upstate Cancer CenterSyracuse, NY		—	—	43.9
40	Louisiana Cancer Research CenterNew Orleans, LA		—	—	43.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →